Quoin Pharmaceuticals Initiates Clinical Testing of Lead Product in Pediatric Netherton Syndrome Patient
Clinical Assessment Is Being Performed on a Pediatric Patient at Children’s Health Ireland in Dublin First Evaluation of ...
Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU)
Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.
HealthDay on MSN12h
Milk Protein Allergy: What It Is, Symptoms, Causes & Treatment
Milk protein allergy (MPA), also known as food protein induced allergic proctocolitis (FPIAP), is one of the most common ...
Malaria developing resistance to drug used to treat children
The malaria parasite may be gaining resistance against artemisinin, the drug most often used to try and save children with ...
healthday20h
Fevers in Children: Causes, Treatments and When to be Concerned
Fever is one of the most common reasons parents seek medical care for their children. While it can be alarming, fever is the ...